Similarly, healthy humans administered with CB1R agonist (THC) exhibit psychosis-relevant effects associated with gamma oscillation disorder (coherence reduction during auditory evoked response test; Cortes-Briones et al., 2015). This evidence concerns the gene CNR1 and psychotic disorder.